Obesity
Major Adverse Liver Outcomes With Tirzepatide and Injectable Semaglutide in Adults With Overweight or Obesity and Type 2 Diabetes
Cohort study in peopleInterventions
The paper
Vivekananda Institute of Medical Sciences; Royal Cornwall Hospital Trust
Obesity, 19 Aug 2026
